EVERSANA

News

ConTIPI starts rollout of pelvic organ prolapse device in US

A non-invasive device that could help millions of women in the US with a condition known as pelvic organ prolapse (POP) has launched in the US.

News

EVERSANA partners Oracle on pharmacovigilance platform

EVERSANA has signed an agreement with Oracle Argus Cloud to add to the features of its pharmacovigilance platform, which helps manufacturers monitor drug safety in an increasingly complex p

Digital

Doctor connecting continuous glucose monitor with smartphone

Digital innovation and the Direct-To-Patient Model

Innovation is of no worth if it doesn’t provide better outcomes for patients. Indeed, such advancements should hold as centre the amelioration of the overall patient experience.

Digital

From PDURS to D2C, Frontiers Health speaks to cutting edge h...

Premiere healthcare innovation event Frontiers Health is just under a month away.

Oncology

ESMO 2024 EVERSANA, Ann Marie Robertson, Vanitha Sankaran, Gurdip Daffu, Barry Vucsko,

Oncology today: EVERSANA and pharmaphorum at ESMO 2024

The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scient

Oncology

EVERSANA and pharmaphorum in conversation: ESMO 2024